BETHESDA, Md., Sept. 9, 2026 /PRNewswire/ — AGNC Investment Corp. (Nasdaq: AGNC) announced today that its Board of Directors has declared a cash dividend of $0.12 per share of common stock for September 2026. The dividend is payable on October 9, 2026 to common stockholders of record as of September 30, 2026.

For further information or questions, please contact Investor Relations at (301) 968-9300 or IR@AGNC.com

ABOUT AGNC INVESTMENT CORP.
Founded in 2008, AGNC Investment Corp. (Nasdaq: AGNC) is a leading investor in Agency residential mortgage-backed securities (Agency MBS), which benefit from a guarantee against credit losses by Fannie Mae, Freddie Mac, or Ginnie Mae. We invest on a leveraged basis, financing our Agency MBS assets primarily through repurchase agreements, and utilize dynamic risk management strategies intended to protect the value of our portfolio from interest rate and other market risks.

AGNC has a track record of providing favorable long-term returns for our stockholders through substantial monthly dividend income, with over $16 billion of common stock dividends paid since inception. Our business is a significant source of private capital for the U.S. residential housing market, and our team has extensive experience managing mortgage assets across market cycles. To learn more about The Premier Agency Residential Mortgage REIT, please visit www.AGNC.com, follow us on LinkedIn and X, and sign up for Investor Alerts.   

CONTACT:
Investor Relations – (301) 968-9300

View original content:https://www.prnewswire.com/news-releases/agnc-investment-corp-declares-monthly-common-stock-dividend-of-0-12-per-common-share-for-september-2026–302874182.html

SOURCE AGNC Investment Corp.

Coming later this year, Apple Health app users will be able to conveniently and securely purchase and receive results of Quest’s biomarker lab testing directly in the app

SECAUCUS, N.J., Sept. 9, 2026 /PRNewswire/ — Quest Diagnostics (NYSE: DGX) today announced that Apple Health app users in the United States1 will be able to conveniently purchase a tailored Quest laboratory test panel that includes over 50 biomarkers directly through the app on iPhone and iPad later this year. Apple first announced the upcoming update today at its September event.

“By embedding the Quest lab testing experience within the Apple Health app, we are making testing simpler, smarter and more available to people who want to connect biomarker and biometric insights to own their health,” said Richard Adams, Senior Vice President and General Manager, Consumer, Quest Diagnostics. “This integration will help bridge the gap between clinical and consumer health and serve the growing interest in preventive health and wellness.” 

The Quest laboratory panel is designed to deliver preventive health insights and includes biomarkers for assessing cardiometabolic health and organ function. The panel also includes biometric readings that measure blood pressure, height, weight, and waist and hip circumferences, which may provide additional insights into metabolic health. 

Users can purchase and schedule their blood draw and biometric readings at one of Quest’s approximately 2,000 patient service centers in the United States for $119.

Shortly after testing, lab results will appear within the Apple Health app. Quest collaborates with third-party providers to review and approve all test orders and, at the user’s request, discuss test results and next steps for no additional charge. 

Chronic health conditions, such as heart disease and diabetes, affect as many as three in four American adults, yet can often be prevented if acted upon in early stages, according to the U.S. Centers for Disease Control and Prevention. Biomarker laboratory testing can identify early, asymptomatic signals of several chronic conditions, empowering individuals to make behavioral changes to reduce disease risk.

About Quest Diagnostics
Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We help connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, our insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three adult Americans each year, and our nearly 60,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www.QuestDiagnostics.com 

1.Not available in all U.S. states.

View original content to download multimedia:https://www.prnewswire.com/news-releases/apple-health-app-users-to-be-able-to-order-labs-from-quest-diagnostics-302874147.html

SOURCE Quest Diagnostics

COLUMBUS, Ohio, Sept. 9, 2026 /PRNewswire/ — Huntington Bancshares Incorporated (Nasdaq: HBAN) will participate in the 2026 Barclays Global Financial Conference on Wednesday, September 16, 2026. Steve Steinour, chairman and chief executive officer, and Zach Wasserman, chief financial officer, are scheduled to present to analysts and investors at 7:30 AM (Eastern Time). They will discuss business trends, financial performance, and strategic initiatives. The presentation will include forward-looking statements.

Webcast Information

Interested investors may access the live audio webcast in the investor relations section of Huntington’s website (www.huntington-ir.com). A replay of the webcast will be archived on the website.

About Huntington

Huntington Bancshares Incorporated is a $284 billion asset regional bank holding company headquartered in Columbus, Ohio. A top 10 U.S. commercial bank, The Huntington National Bank and its affiliates provide consumers, small and middle-market businesses, corporations, municipalities, and other organizations with a comprehensive suite of banking, payments, wealth management, and risk management products and services. Founded in 1866, Huntington operates over 1,400 branches in 21 states, with certain businesses operating nationally. Visit Huntington.com for more information.

View original content to download multimedia:https://www.prnewswire.com/news-releases/huntington-bancshares-incorporated-to-present-at-the-2026-barclays-global-financial-conference-302874231.html

SOURCE Huntington Bancshares Incorporated